Influence of Sugar on the Bioavailability of Cocoa Flavanols

Sponsor
University of Reading (Other)
Overall Status
Completed
CT.gov ID
NCT01292967
Collaborator
(none)
15
1
3
2
7.5

Study Details

Study Description

Brief Summary

The primary propose of this study is to determine the impact of ingredients and matrices on flavanol absorption and metabolism.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Low flavanol chocolate
  • Dietary Supplement: High-flavanol with sugar
  • Dietary Supplement: High flavanol Maltitol
N/A

Detailed Description

The investigators have conducted a randomized, triple-blind, cross-over study in 15 healthy human volunteers to investigate the absorption and metabolism of cocoa flavanols from a high-flavanol chocolate made with added sugar and a high-flavanol chocolate containing the sugar substitute maltitol; a nutrient-matched low flavanol control product was also fed. All products were matched for macro-nutrients, as well as for alkaloids (theobromine and caffeine), and were similar in taste and appearance. Both high-flavanol products contained ~259 mg cocoa flavanols, whilst the low-flavanol chocolate contained 48 mg of cocoa flavanols. On each study day, subjects were cannulated and baseline blood samples were collected prior to consumption of any of the test chocolates. Additional blood samples were collected at 1, 2 and 4 hours and plasma levels of flavanols were assessed using HPLC with fluorescence detection. All test products were well-tolerated by study participants.

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Basic Science
Official Title:
The Influence of Maltitol on the Absorption and Metabolism of Flavanols From Chocolate
Study Start Date :
Apr 1, 2008
Actual Primary Completion Date :
Jun 1, 2008
Actual Study Completion Date :
Jun 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Low flavanol

Low-flavanol chocolate contained 48 mg of cocoa flavanols. macro- and micro-nutrient matched with active comparator

Dietary Supplement: Low flavanol chocolate
48 mg of total flavanols from cocoa

Active Comparator: High-flavanol with sugar

High-flavanol chocolate made with added sugar containing 251 mg of cocoa flavanols

Dietary Supplement: High-flavanol with sugar
high-flavanol containing 251 mg cocoa flavanols

Active Comparator: High flavanol Maltitol

High-flavanol chocolate made with the sugar substitute maltitol containing 266 mg cocoa flavanols

Dietary Supplement: High flavanol Maltitol
high-flavanol containing 266 mg cocoa flavanols

Outcome Measures

Primary Outcome Measures

  1. Impact of ingredients and matrices on flavanol absorption and metabolism. [4 hours]

    The absorption and metabolism of cocoa flavanols from a high-flavanol chocolate made with added sugar and a high-flavanol chocolate containing the sugar substitute maltitol will be assessed by using HPLC with fluorescence detection

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • a signed consent form

  • age of 18-50 years inclusive

Exclusion Criteria:
  • did not suffer from any form of disease, including liver disease, diabetes mellitus or a myocardial infarction

  • not on medications for the treatment of hypertension, elevated lipids or diabetes (type I and II).

  • did not suffered gall bladder problems or abnormalities of fat metabolism

  • weight reducing dietary regimen or taking any dietary supplements, including dietary fatty acids

  • did not consume more than 15 units (120g) of alcohol per week

  • did not have sensitivities to chocolate, reduced calorie sweeteners, dairy, nuts or gluten.

  • Vegetarians and vegans

  • taken antibiotics in the last 8 weeks

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Reading Reading Berkshire United Kingdom RG6 6AP

Sponsors and Collaborators

  • University of Reading

Investigators

  • Principal Investigator: Jeremy Spencer, PhD, University of Reading

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01292967
Other Study ID Numbers:
  • UReading-2010_03
First Posted:
Feb 10, 2011
Last Update Posted:
Feb 10, 2011
Last Verified:
Dec 1, 2010

Study Results

No Results Posted as of Feb 10, 2011